nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SCN8A—epilepsy syndrome	0.0747	0.201	CbGaD
Procainamide—SCN9A—epilepsy syndrome	0.0604	0.162	CbGaD
Procainamide—SCN3A—epilepsy syndrome	0.0578	0.155	CbGaD
Procainamide—SCN4A—epilepsy syndrome	0.0555	0.149	CbGaD
Procainamide—SCN1A—epilepsy syndrome	0.0406	0.109	CbGaD
Procainamide—SCN2A—epilepsy syndrome	0.0358	0.0962	CbGaD
Procainamide—SCN7A—Rufinamide—epilepsy syndrome	0.025	0.0579	CbGbCtD
Procainamide—CHRM2—epilepsy syndrome	0.0206	0.0555	CbGaD
Procainamide—SCN11A—Rufinamide—epilepsy syndrome	0.0198	0.046	CbGbCtD
Procainamide—SCN8A—Lamotrigine—epilepsy syndrome	0.0188	0.0436	CbGbCtD
Procainamide—BCHE—epilepsy syndrome	0.0172	0.0463	CbGaD
Procainamide—SCN8A—Rufinamide—epilepsy syndrome	0.0166	0.0385	CbGbCtD
Procainamide—SCN8A—Phenytoin—epilepsy syndrome	0.0145	0.0337	CbGbCtD
Procainamide—SCN11A—Zonisamide—epilepsy syndrome	0.0143	0.0332	CbGbCtD
Procainamide—SCN9A—Lamotrigine—epilepsy syndrome	0.0123	0.0285	CbGbCtD
Procainamide—SCN9A—Lacosamide—epilepsy syndrome	0.0123	0.0285	CbGbCtD
Procainamide—SCN3A—Lacosamide—epilepsy syndrome	0.0112	0.0261	CbGbCtD
Procainamide—SCN3A—Lamotrigine—epilepsy syndrome	0.0112	0.0261	CbGbCtD
Procainamide—SCN9A—Rufinamide—epilepsy syndrome	0.0109	0.0252	CbGbCtD
Procainamide—SCN9A—Carbamazepine—epilepsy syndrome	0.0106	0.0245	CbGbCtD
Procainamide—SCN2A—Lamotrigine—epilepsy syndrome	0.0104	0.0241	CbGbCtD
Procainamide—SCN4A—Lamotrigine—epilepsy syndrome	0.0104	0.0241	CbGbCtD
Procainamide—SCN3A—Rufinamide—epilepsy syndrome	0.00993	0.023	CbGbCtD
Procainamide—SCN1A—Lamotrigine—epilepsy syndrome	0.00965	0.0224	CbGbCtD
Procainamide—SCN10A—Lamotrigine—epilepsy syndrome	0.00965	0.0224	CbGbCtD
Procainamide—SCN10A—Lacosamide—epilepsy syndrome	0.00965	0.0224	CbGbCtD
Procainamide—SCN9A—Phenytoin—epilepsy syndrome	0.00949	0.022	CbGbCtD
Procainamide—CYP2D6—epilepsy syndrome	0.00945	0.0254	CbGaD
Procainamide—SCN2A—Rufinamide—epilepsy syndrome	0.00917	0.0213	CbGbCtD
Procainamide—SCN4A—Rufinamide—epilepsy syndrome	0.00917	0.0213	CbGbCtD
Procainamide—SCN5A—Oxcarbazepine—epilepsy syndrome	0.00904	0.021	CbGbCtD
Procainamide—SCN4A—Carbamazepine—epilepsy syndrome	0.00894	0.0207	CbGbCtD
Procainamide—SCN3A—Phenytoin—epilepsy syndrome	0.00868	0.0201	CbGbCtD
Procainamide—SCN10A—Rufinamide—epilepsy syndrome	0.00853	0.0198	CbGbCtD
Procainamide—SCN1A—Rufinamide—epilepsy syndrome	0.00853	0.0198	CbGbCtD
Procainamide—SCN2A—Phenytoin—epilepsy syndrome	0.00801	0.0186	CbGbCtD
Procainamide—SCN4A—Phenytoin—epilepsy syndrome	0.00801	0.0186	CbGbCtD
Procainamide—SCN5A—Fosphenytoin—epilepsy syndrome	0.00791	0.0183	CbGbCtD
Procainamide—SCN9A—Zonisamide—epilepsy syndrome	0.00783	0.0182	CbGbCtD
Procainamide—SCN2A—Propofol—epilepsy syndrome	0.00747	0.0173	CbGbCtD
Procainamide—SCN4A—Propofol—epilepsy syndrome	0.00747	0.0173	CbGbCtD
Procainamide—SCN1A—Phenytoin—epilepsy syndrome	0.00745	0.0173	CbGbCtD
Procainamide—SCN3A—Zonisamide—epilepsy syndrome	0.00716	0.0166	CbGbCtD
Procainamide—SCN2A—Zonisamide—epilepsy syndrome	0.00661	0.0153	CbGbCtD
Procainamide—SCN4A—Zonisamide—epilepsy syndrome	0.00661	0.0153	CbGbCtD
Procainamide—SCN5A—Lamotrigine—epilepsy syndrome	0.0066	0.0153	CbGbCtD
Procainamide—SCN1A—Zonisamide—epilepsy syndrome	0.00615	0.0143	CbGbCtD
Procainamide—SCN5A—Rufinamide—epilepsy syndrome	0.00583	0.0135	CbGbCtD
Procainamide—SCN5A—Carbamazepine—epilepsy syndrome	0.00568	0.0132	CbGbCtD
Procainamide—SCN5A—Phenytoin—epilepsy syndrome	0.00509	0.0118	CbGbCtD
Procainamide—SCN1A—Topiramate—epilepsy syndrome	0.00448	0.0104	CbGbCtD
Procainamide—SCN5A—Zonisamide—epilepsy syndrome	0.0042	0.00975	CbGbCtD
Procainamide—SCN3A—spinal nerve—epilepsy syndrome	0.00331	0.0973	CbGeAlD
Procainamide—SCN5A—Topiramate—epilepsy syndrome	0.00306	0.0071	CbGbCtD
Procainamide—SLC22A1—Midazolam—epilepsy syndrome	0.00296	0.00687	CbGbCtD
Procainamide—SCN8A—cerebellar cortex—epilepsy syndrome	0.00285	0.0839	CbGeAlD
Procainamide—SLC22A5—Valproic Acid—epilepsy syndrome	0.00271	0.00629	CbGbCtD
Procainamide—SCN11A—ganglion—epilepsy syndrome	0.00136	0.0401	CbGeAlD
Procainamide—CYP2D6—Propofol—epilepsy syndrome	0.000908	0.00211	CbGbCtD
Procainamide—SCN8A—hindbrain—epilepsy syndrome	0.000783	0.023	CbGeAlD
Procainamide—SCN10A—ganglion—epilepsy syndrome	0.000691	0.0203	CbGeAlD
Procainamide—SCN1A—hindbrain—epilepsy syndrome	0.000592	0.0174	CbGeAlD
Procainamide—SCN2A—hindbrain—epilepsy syndrome	0.000544	0.016	CbGeAlD
Procainamide—SLC22A1—ganglion—epilepsy syndrome	0.000525	0.0154	CbGeAlD
Procainamide—SLC22A3—tongue—epilepsy syndrome	0.000497	0.0146	CbGeAlD
Procainamide—Lucanthone—APEX1—epilepsy syndrome	0.000452	0.13	CrCbGaD
Procainamide—SCN8A—brainstem—epilepsy syndrome	0.000449	0.0132	CbGeAlD
Procainamide—SCN8A—forebrain—epilepsy syndrome	0.000433	0.0127	CbGeAlD
Procainamide—SCN8A—telencephalon—epilepsy syndrome	0.000399	0.0117	CbGeAlD
Procainamide—DNMT1—forebrain—epilepsy syndrome	0.000374	0.011	CbGeAlD
Procainamide—SCN11A—spinal cord—epilepsy syndrome	0.000368	0.0108	CbGeAlD
Procainamide—DNMT1—telencephalon—epilepsy syndrome	0.000343	0.0101	CbGeAlD
Procainamide—SCN1A—brainstem—epilepsy syndrome	0.000339	0.00998	CbGeAlD
Procainamide—SCN1A—forebrain—epilepsy syndrome	0.000328	0.00963	CbGeAlD
Procainamide—SCN11A—head—epilepsy syndrome	0.000327	0.00962	CbGeAlD
Procainamide—SCN2A—brainstem—epilepsy syndrome	0.000312	0.00916	CbGeAlD
Procainamide—SCN11A—nervous system—epilepsy syndrome	0.00031	0.00912	CbGeAlD
Procainamide—SCN1A—telencephalon—epilepsy syndrome	0.000301	0.00886	CbGeAlD
Procainamide—SCN2A—forebrain—epilepsy syndrome	0.000301	0.00884	CbGeAlD
Procainamide—SCN11A—central nervous system—epilepsy syndrome	0.000299	0.00879	CbGeAlD
Procainamide—SCN10A—forebrain—epilepsy syndrome	0.00029	0.00852	CbGeAlD
Procainamide—SCN8A—spinal cord—epilepsy syndrome	0.000279	0.00821	CbGeAlD
Procainamide—ACHE—telencephalon—epilepsy syndrome	0.000279	0.0082	CbGeAlD
Procainamide—SCN7A—head—epilepsy syndrome	0.000278	0.00818	CbGeAlD
Procainamide—SCN2A—telencephalon—epilepsy syndrome	0.000276	0.00813	CbGeAlD
Procainamide—DNMT1—medulla oblongata—epilepsy syndrome	0.00027	0.00793	CbGeAlD
Procainamide—SCN10A—telencephalon—epilepsy syndrome	0.000267	0.00784	CbGeAlD
Procainamide—SCN3A—forebrain—epilepsy syndrome	0.000264	0.00777	CbGeAlD
Procainamide—SCN9A—midbrain—epilepsy syndrome	0.000251	0.00739	CbGeAlD
Procainamide—SCN8A—head—epilepsy syndrome	0.000248	0.00729	CbGeAlD
Procainamide—DNMT1—midbrain—epilepsy syndrome	0.000247	0.00725	CbGeAlD
Procainamide—SCN9A—spinal cord—epilepsy syndrome	0.000245	0.00721	CbGeAlD
Procainamide—SCN3A—telencephalon—epilepsy syndrome	0.000243	0.00714	CbGeAlD
Procainamide—DNMT1—spinal cord—epilepsy syndrome	0.000241	0.00707	CbGeAlD
Procainamide—SCN11A—brain—epilepsy syndrome	0.000237	0.00697	CbGeAlD
Procainamide—SCN1A—medulla oblongata—epilepsy syndrome	0.000237	0.00696	CbGeAlD
Procainamide—SCN8A—nervous system—epilepsy syndrome	0.000235	0.00692	CbGeAlD
Procainamide—Sunitinib—ERN1—epilepsy syndrome	0.000228	0.0657	CrCbGaD
Procainamide—SCN8A—central nervous system—epilepsy syndrome	0.000227	0.00666	CbGeAlD
Procainamide—CHRM2—forebrain—epilepsy syndrome	0.000224	0.00659	CbGeAlD
Procainamide—SCN8A—cerebellum—epilepsy syndrome	0.000221	0.00651	CbGeAlD
Procainamide—SLC22A1—forebrain—epilepsy syndrome	0.00022	0.00648	CbGeAlD
Procainamide—ACHE—medulla oblongata—epilepsy syndrome	0.000219	0.00644	CbGeAlD
Procainamide—SCN2A—medulla oblongata—epilepsy syndrome	0.000217	0.00639	CbGeAlD
Procainamide—SCN1A—midbrain—epilepsy syndrome	0.000216	0.00636	CbGeAlD
Procainamide—DNMT1—head—epilepsy syndrome	0.000214	0.00629	CbGeAlD
Procainamide—SCN1A—spinal cord—epilepsy syndrome	0.000211	0.0062	CbGeAlD
Procainamide—CHRM2—telencephalon—epilepsy syndrome	0.000206	0.00606	CbGeAlD
Procainamide—DNMT1—nervous system—epilepsy syndrome	0.000203	0.00596	CbGeAlD
Procainamide—SLC22A1—telencephalon—epilepsy syndrome	0.000203	0.00596	CbGeAlD
Procainamide—SCN7A—brain—epilepsy syndrome	0.000202	0.00593	CbGeAlD
Procainamide—ACHE—midbrain—epilepsy syndrome	0.0002	0.00589	CbGeAlD
Procainamide—SCN2A—midbrain—epilepsy syndrome	0.000199	0.00584	CbGeAlD
Procainamide—ACHE—spinal cord—epilepsy syndrome	0.000196	0.00575	CbGeAlD
Procainamide—DNMT1—central nervous system—epilepsy syndrome	0.000195	0.00574	CbGeAlD
Procainamide—SCN4A—head—epilepsy syndrome	0.000195	0.00572	CbGeAlD
Procainamide—SCN2A—spinal cord—epilepsy syndrome	0.000194	0.00569	CbGeAlD
Procainamide—SCN3A—medulla oblongata—epilepsy syndrome	0.000191	0.00561	CbGeAlD
Procainamide—DNMT1—cerebellum—epilepsy syndrome	0.000191	0.00561	CbGeAlD
Procainamide—SCN1A—head—epilepsy syndrome	0.000188	0.00551	CbGeAlD
Procainamide—SCN10A—spinal cord—epilepsy syndrome	0.000187	0.00549	CbGeAlD
Procainamide—SCN4A—nervous system—epilepsy syndrome	0.000184	0.00542	CbGeAlD
Procainamide—SCN8A—brain—epilepsy syndrome	0.00018	0.00529	CbGeAlD
Procainamide—CYP2D6—hindbrain—epilepsy syndrome	0.000179	0.00525	CbGeAlD
Procainamide—SCN1A—nervous system—epilepsy syndrome	0.000178	0.00523	CbGeAlD
Procainamide—SCN4A—central nervous system—epilepsy syndrome	0.000178	0.00522	CbGeAlD
Procainamide—SCN3A—midbrain—epilepsy syndrome	0.000175	0.00513	CbGeAlD
Procainamide—SCN2A—head—epilepsy syndrome	0.000172	0.00506	CbGeAlD
Procainamide—SCN1A—central nervous system—epilepsy syndrome	0.000171	0.00503	CbGeAlD
Procainamide—SCN3A—spinal cord—epilepsy syndrome	0.00017	0.005	CbGeAlD
Procainamide—SCN1A—cerebellum—epilepsy syndrome	0.000167	0.00492	CbGeAlD
Procainamide—SCN10A—head—epilepsy syndrome	0.000166	0.00488	CbGeAlD
Procainamide—Proparacaine—SCN3A—epilepsy syndrome	0.000164	0.0471	CrCbGaD
Procainamide—SCN2A—nervous system—epilepsy syndrome	0.000163	0.0048	CbGeAlD
Procainamide—SCN9A—brain—epilepsy syndrome	0.000158	0.00465	CbGeAlD
Procainamide—SCN10A—nervous system—epilepsy syndrome	0.000157	0.00463	CbGeAlD
Procainamide—SCN2A—central nervous system—epilepsy syndrome	0.000157	0.00462	CbGeAlD
Procainamide—ACHE—cerebellum—epilepsy syndrome	0.000155	0.00456	CbGeAlD
Procainamide—DNMT1—brain—epilepsy syndrome	0.000155	0.00456	CbGeAlD
Procainamide—BCHE—brainstem—epilepsy syndrome	0.000155	0.00454	CbGeAlD
Procainamide—SCN2A—cerebellum—epilepsy syndrome	0.000154	0.00452	CbGeAlD
Procainamide—SCN10A—central nervous system—epilepsy syndrome	0.000152	0.00445	CbGeAlD
Procainamide—SCN3A—head—epilepsy syndrome	0.000151	0.00445	CbGeAlD
Procainamide—SCN5A—head—epilepsy syndrome	0.000151	0.00444	CbGeAlD
Procainamide—Oxybuprocaine—SCN3A—epilepsy syndrome	0.00015	0.0431	CrCbGaD
Procainamide—BCHE—forebrain—epilepsy syndrome	0.000149	0.00438	CbGeAlD
Procainamide—SLC22A4—spinal cord—epilepsy syndrome	0.000149	0.00438	CbGeAlD
Procainamide—SCN3A—nervous system—epilepsy syndrome	0.000143	0.00422	CbGeAlD
Procainamide—SCN5A—nervous system—epilepsy syndrome	0.000143	0.0042	CbGeAlD
Procainamide—SCN4A—brain—epilepsy syndrome	0.000141	0.00414	CbGeAlD
Procainamide—SCN3A—central nervous system—epilepsy syndrome	0.000138	0.00406	CbGeAlD
Procainamide—SCN5A—central nervous system—epilepsy syndrome	0.000138	0.00405	CbGeAlD
Procainamide—BCHE—telencephalon—epilepsy syndrome	0.000137	0.00403	CbGeAlD
Procainamide—Benzocaine—SCN8A—epilepsy syndrome	0.000136	0.0392	CrCbGaD
Procainamide—SCN1A—brain—epilepsy syndrome	0.000136	0.004	CbGeAlD
Procainamide—SCN3A—cerebellum—epilepsy syndrome	0.000135	0.00397	CbGeAlD
Procainamide—Procaine—CHRNA2—epilepsy syndrome	0.000133	0.0382	CrCbGaD
Procainamide—Sunitinib—TYRO3—epilepsy syndrome	0.000131	0.0377	CrCbGaD
Procainamide—CHRM2—head—epilepsy syndrome	0.000128	0.00378	CbGeAlD
Procainamide—SLC22A1—head—epilepsy syndrome	0.000126	0.00371	CbGeAlD
Procainamide—ACHE—brain—epilepsy syndrome	0.000126	0.0037	CbGeAlD
Procainamide—SCN2A—brain—epilepsy syndrome	0.000125	0.00367	CbGeAlD
Procainamide—CHRM2—nervous system—epilepsy syndrome	0.000122	0.00358	CbGeAlD
Procainamide—SLC22A3—head—epilepsy syndrome	0.000121	0.00354	CbGeAlD
Procainamide—SCN10A—brain—epilepsy syndrome	0.00012	0.00354	CbGeAlD
Procainamide—SLC22A1—nervous system—epilepsy syndrome	0.00012	0.00352	CbGeAlD
Procainamide—SLC22A4—cerebellum—epilepsy syndrome	0.000118	0.00347	CbGeAlD
Procainamide—CHRM2—central nervous system—epilepsy syndrome	0.000117	0.00345	CbGeAlD
Procainamide—SLC22A1—central nervous system—epilepsy syndrome	0.000115	0.00339	CbGeAlD
Procainamide—Proparacaine—SCN1A—epilepsy syndrome	0.000115	0.033	CrCbGaD
Procainamide—SLC22A3—nervous system—epilepsy syndrome	0.000114	0.00336	CbGeAlD
Procainamide—SLC22A5—medulla oblongata—epilepsy syndrome	0.000111	0.00325	CbGeAlD
Procainamide—Benzocaine—SCN9A—epilepsy syndrome	0.00011	0.0317	CrCbGaD
Procainamide—SLC22A3—central nervous system—epilepsy syndrome	0.00011	0.00324	CbGeAlD
Procainamide—SCN3A—brain—epilepsy syndrome	0.00011	0.00322	CbGeAlD
Procainamide—SCN5A—brain—epilepsy syndrome	0.000109	0.00321	CbGeAlD
Procainamide—BCHE—medulla oblongata—epilepsy syndrome	0.000108	0.00317	CbGeAlD
Procainamide—Benzocaine—SCN3A—epilepsy syndrome	0.000105	0.0303	CrCbGaD
Procainamide—Oxybuprocaine—SCN1A—epilepsy syndrome	0.000105	0.0302	CrCbGaD
Procainamide—CYP2D6—brainstem—epilepsy syndrome	0.000102	0.00301	CbGeAlD
Procainamide—Benzocaine—SCN4A—epilepsy syndrome	0.000101	0.0291	CrCbGaD
Procainamide—Proparacaine—SCN2A—epilepsy syndrome	0.000101	0.0291	CrCbGaD
Procainamide—SLC22A5—midbrain—epilepsy syndrome	0.000101	0.00297	CbGeAlD
Procainamide—Sunitinib—FYN—epilepsy syndrome	9.94e-05	0.0286	CrCbGaD
Procainamide—CYP2D6—forebrain—epilepsy syndrome	9.88e-05	0.0029	CbGeAlD
Procainamide—SLC22A5—spinal cord—epilepsy syndrome	9.87e-05	0.0029	CbGeAlD
Procainamide—BCHE—midbrain—epilepsy syndrome	9.85e-05	0.00289	CbGeAlD
Procainamide—BCHE—spinal cord—epilepsy syndrome	9.61e-05	0.00282	CbGeAlD
Procainamide—SLC22A4—brain—epilepsy syndrome	9.6e-05	0.00282	CbGeAlD
Procainamide—CHRM2—brain—epilepsy syndrome	9.31e-05	0.00274	CbGeAlD
Procainamide—Oxybuprocaine—SCN2A—epilepsy syndrome	9.26e-05	0.0267	CrCbGaD
Procainamide—SLC22A1—brain—epilepsy syndrome	9.14e-05	0.00269	CbGeAlD
Procainamide—CYP2D6—telencephalon—epilepsy syndrome	9.09e-05	0.00267	CbGeAlD
Procainamide—Lidocaine—SCN9A—epilepsy syndrome	8.99e-05	0.0259	CrCbGaD
Procainamide—SLC22A3—brain—epilepsy syndrome	8.74e-05	0.00257	CbGeAlD
Procainamide—Lidocaine—SCN3A—epilepsy syndrome	8.59e-05	0.0247	CrCbGaD
Procainamide—BCHE—head—epilepsy syndrome	8.54e-05	0.00251	CbGeAlD
Procainamide—Sunitinib—PTK2B—epilepsy syndrome	8.45e-05	0.0243	CrCbGaD
Procainamide—Lidocaine—SCN4A—epilepsy syndrome	8.26e-05	0.0238	CrCbGaD
Procainamide—BCHE—nervous system—epilepsy syndrome	8.1e-05	0.00238	CbGeAlD
Procainamide—SLC22A5—cerebellum—epilepsy syndrome	7.82e-05	0.0023	CbGeAlD
Procainamide—BCHE—central nervous system—epilepsy syndrome	7.79e-05	0.00229	CbGeAlD
Procainamide—BCHE—cerebellum—epilepsy syndrome	7.62e-05	0.00224	CbGeAlD
Procainamide—Benzocaine—SCN1A—epilepsy syndrome	7.4e-05	0.0213	CrCbGaD
Procainamide—Sunitinib—RET—epilepsy syndrome	7.19e-05	0.0207	CrCbGaD
Procainamide—Benzocaine—SCN2A—epilepsy syndrome	6.53e-05	0.0188	CrCbGaD
Procainamide—SLC22A5—brain—epilepsy syndrome	6.35e-05	0.00187	CbGeAlD
Procainamide—BCHE—brain—epilepsy syndrome	6.19e-05	0.00182	CbGeAlD
Procainamide—Probenecid—SLCO1A2—epilepsy syndrome	5.93e-05	0.0171	CrCbGaD
Procainamide—Dizziness—Acetazolamide—epilepsy syndrome	5.88e-05	0.000738	CcSEcCtD
Procainamide—Hypersensitivity—Levetiracetam—epilepsy syndrome	5.88e-05	0.000738	CcSEcCtD
Procainamide—Urticaria—Diazepam—epilepsy syndrome	5.87e-05	0.000737	CcSEcCtD
Procainamide—Decreased appetite—Clonazepam—epilepsy syndrome	5.86e-05	0.000736	CcSEcCtD
Procainamide—Aminohippurate—SLCO1A2—epilepsy syndrome	5.85e-05	0.0168	CrCbGaD
Procainamide—Gastrointestinal pain—Felbamate—epilepsy syndrome	5.85e-05	0.000734	CcSEcCtD
Procainamide—Pruritus—Propofol—epilepsy syndrome	5.84e-05	0.000733	CcSEcCtD
Procainamide—Abdominal pain—Diazepam—epilepsy syndrome	5.84e-05	0.000733	CcSEcCtD
Procainamide—Bradycardia—Gabapentin—epilepsy syndrome	5.83e-05	0.000732	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	5.83e-05	0.000731	CcSEcCtD
Procainamide—Decreased appetite—Phenytoin—epilepsy syndrome	5.82e-05	0.000731	CcSEcCtD
Procainamide—Cardiac disorder—Pregabalin—epilepsy syndrome	5.8e-05	0.000728	CcSEcCtD
Procainamide—Flushing—Pregabalin—epilepsy syndrome	5.8e-05	0.000728	CcSEcCtD
Procainamide—Asthenia—Midazolam—epilepsy syndrome	5.8e-05	0.000727	CcSEcCtD
Procainamide—Decreased appetite—Oxcarbazepine—epilepsy syndrome	5.79e-05	0.000727	CcSEcCtD
Procainamide—Abdominal discomfort—Topiramate—epilepsy syndrome	5.78e-05	0.000725	CcSEcCtD
Procainamide—Feeling abnormal—Zonisamide—epilepsy syndrome	5.77e-05	0.000724	CcSEcCtD
Procainamide—Gastrointestinal pain—Zonisamide—epilepsy syndrome	5.72e-05	0.000718	CcSEcCtD
Procainamide—Asthenia—Levetiracetam—epilepsy syndrome	5.72e-05	0.000718	CcSEcCtD
Procainamide—Pruritus—Midazolam—epilepsy syndrome	5.71e-05	0.000717	CcSEcCtD
Procainamide—Hallucination—Gabapentin—epilepsy syndrome	5.7e-05	0.000716	CcSEcCtD
Procainamide—Urticaria—Felbamate—epilepsy syndrome	5.68e-05	0.000713	CcSEcCtD
Procainamide—CYP2D6—head—epilepsy syndrome	5.66e-05	0.00166	CbGeAlD
Procainamide—Abdominal pain—Felbamate—epilepsy syndrome	5.65e-05	0.00071	CcSEcCtD
Procainamide—Body temperature increased—Felbamate—epilepsy syndrome	5.65e-05	0.00071	CcSEcCtD
Procainamide—Vomiting—Acetazolamide—epilepsy syndrome	5.65e-05	0.000709	CcSEcCtD
Procainamide—Diarrhoea—Propofol—epilepsy syndrome	5.65e-05	0.000709	CcSEcCtD
Procainamide—Pruritus—Levetiracetam—epilepsy syndrome	5.64e-05	0.000708	CcSEcCtD
Procainamide—Neutropenia—Topiramate—epilepsy syndrome	5.63e-05	0.000707	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	5.63e-05	0.000707	CcSEcCtD
Procainamide—Chills—Pregabalin—epilepsy syndrome	5.61e-05	0.000704	CcSEcCtD
Procainamide—Ill-defined disorder—Valproic Acid—epilepsy syndrome	5.58e-05	0.000701	CcSEcCtD
Procainamide—Urticaria—Zonisamide—epilepsy syndrome	5.56e-05	0.000698	CcSEcCtD
Procainamide—Decreased appetite—Carbamazepine—epilepsy syndrome	5.56e-05	0.000698	CcSEcCtD
Procainamide—Feeling abnormal—Clonazepam—epilepsy syndrome	5.56e-05	0.000698	CcSEcCtD
Procainamide—Abdominal pain—Zonisamide—epilepsy syndrome	5.53e-05	0.000695	CcSEcCtD
Procainamide—Body temperature increased—Zonisamide—epilepsy syndrome	5.53e-05	0.000695	CcSEcCtD
Procainamide—Hypersensitivity—Vigabatrin—epilepsy syndrome	5.53e-05	0.000694	CcSEcCtD
Procainamide—Asthenia—Fosphenytoin—epilepsy syndrome	5.52e-05	0.000693	CcSEcCtD
Procainamide—Feeling abnormal—Phenytoin—epilepsy syndrome	5.52e-05	0.000693	CcSEcCtD
Procainamide—Gastrointestinal pain—Clonazepam—epilepsy syndrome	5.52e-05	0.000692	CcSEcCtD
Procainamide—Angioedema—Valproic Acid—epilepsy syndrome	5.5e-05	0.00069	CcSEcCtD
Procainamide—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	5.49e-05	0.000689	CcSEcCtD
Procainamide—Dizziness—Propofol—epilepsy syndrome	5.46e-05	0.000685	CcSEcCtD
Procainamide—Diarrhoea—Levetiracetam—epilepsy syndrome	5.46e-05	0.000685	CcSEcCtD
Procainamide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	5.45e-05	0.000684	CcSEcCtD
Procainamide—Pruritus—Fosphenytoin—epilepsy syndrome	5.45e-05	0.000684	CcSEcCtD
Procainamide—Hypersensitivity—Diazepam—epilepsy syndrome	5.44e-05	0.000683	CcSEcCtD
Procainamide—Malaise—Valproic Acid—epilepsy syndrome	5.43e-05	0.000681	CcSEcCtD
Procainamide—Asthenia—Vigabatrin—epilepsy syndrome	5.38e-05	0.000676	CcSEcCtD
Procainamide—Decreased appetite—Lamotrigine—epilepsy syndrome	5.37e-05	0.000674	CcSEcCtD
Procainamide—CYP2D6—nervous system—epilepsy syndrome	5.36e-05	0.00158	CbGeAlD
Procainamide—Urticaria—Clonazepam—epilepsy syndrome	5.36e-05	0.000673	CcSEcCtD
Procainamide—Depression—Topiramate—epilepsy syndrome	5.36e-05	0.000672	CcSEcCtD
Procainamide—Dizziness—Midazolam—epilepsy syndrome	5.34e-05	0.00067	CcSEcCtD
Procainamide—Body temperature increased—Clonazepam—epilepsy syndrome	5.33e-05	0.000669	CcSEcCtD
Procainamide—Abdominal pain—Clonazepam—epilepsy syndrome	5.33e-05	0.000669	CcSEcCtD
Procainamide—Dysgeusia—Pregabalin—epilepsy syndrome	5.33e-05	0.000669	CcSEcCtD
Procainamide—Urticaria—Phenytoin—epilepsy syndrome	5.32e-05	0.000668	CcSEcCtD
Procainamide—Lidocaine—SCN2A—epilepsy syndrome	5.32e-05	0.0153	CrCbGaD
Procainamide—Cardiac disorder—Gabapentin—epilepsy syndrome	5.32e-05	0.000668	CcSEcCtD
Procainamide—Pruritus—Vigabatrin—epilepsy syndrome	5.31e-05	0.000666	CcSEcCtD
Procainamide—Asthenia—Diazepam—epilepsy syndrome	5.3e-05	0.000665	CcSEcCtD
Procainamide—Body temperature increased—Phenytoin—epilepsy syndrome	5.3e-05	0.000665	CcSEcCtD
Procainamide—Urticaria—Oxcarbazepine—epilepsy syndrome	5.29e-05	0.000665	CcSEcCtD
Procainamide—Renal failure—Topiramate—epilepsy syndrome	5.28e-05	0.000663	CcSEcCtD
Procainamide—Nausea—Acetazolamide—epilepsy syndrome	5.28e-05	0.000663	CcSEcCtD
Procainamide—Dizziness—Levetiracetam—epilepsy syndrome	5.27e-05	0.000662	CcSEcCtD
Procainamide—Feeling abnormal—Carbamazepine—epilepsy syndrome	5.27e-05	0.000662	CcSEcCtD
Procainamide—Body temperature increased—Oxcarbazepine—epilepsy syndrome	5.27e-05	0.000661	CcSEcCtD
Procainamide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	5.27e-05	0.000661	CcSEcCtD
Procainamide—Diarrhoea—Fosphenytoin—epilepsy syndrome	5.27e-05	0.000661	CcSEcCtD
Procainamide—Vomiting—Propofol—epilepsy syndrome	5.25e-05	0.000659	CcSEcCtD
Procainamide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	5.23e-05	0.000656	CcSEcCtD
Procainamide—Pruritus—Diazepam—epilepsy syndrome	5.23e-05	0.000656	CcSEcCtD
Procainamide—CYP2D6—central nervous system—epilepsy syndrome	5.16e-05	0.00152	CbGeAlD
Procainamide—Hypersensitivity—Zonisamide—epilepsy syndrome	5.16e-05	0.000647	CcSEcCtD
Procainamide—Chills—Gabapentin—epilepsy syndrome	5.14e-05	0.000646	CcSEcCtD
Procainamide—Vomiting—Midazolam—epilepsy syndrome	5.14e-05	0.000645	CcSEcCtD
Procainamide—Diarrhoea—Vigabatrin—epilepsy syndrome	5.13e-05	0.000645	CcSEcCtD
Procainamide—Asthenia—Felbamate—epilepsy syndrome	5.13e-05	0.000644	CcSEcCtD
Procainamide—Arthralgia—Valproic Acid—epilepsy syndrome	5.12e-05	0.000643	CcSEcCtD
Procainamide—Myalgia—Valproic Acid—epilepsy syndrome	5.12e-05	0.000643	CcSEcCtD
Procainamide—Feeling abnormal—Lamotrigine—epilepsy syndrome	5.09e-05	0.000639	CcSEcCtD
Procainamide—Dizziness—Fosphenytoin—epilepsy syndrome	5.09e-05	0.000639	CcSEcCtD
Procainamide—Urticaria—Carbamazepine—epilepsy syndrome	5.08e-05	0.000638	CcSEcCtD
Procainamide—Vomiting—Levetiracetam—epilepsy syndrome	5.07e-05	0.000637	CcSEcCtD
Procainamide—Discomfort—Valproic Acid—epilepsy syndrome	5.06e-05	0.000635	CcSEcCtD
Procainamide—Pruritus—Felbamate—epilepsy syndrome	5.06e-05	0.000635	CcSEcCtD
Procainamide—Abdominal pain—Carbamazepine—epilepsy syndrome	5.06e-05	0.000635	CcSEcCtD
Procainamide—Body temperature increased—Carbamazepine—epilepsy syndrome	5.06e-05	0.000635	CcSEcCtD
Procainamide—Diarrhoea—Diazepam—epilepsy syndrome	5.05e-05	0.000635	CcSEcCtD
Procainamide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.05e-05	0.000634	CcSEcCtD
Procainamide—Ill-defined disorder—Pregabalin—epilepsy syndrome	5.05e-05	0.000634	CcSEcCtD
Procainamide—CYP2D6—cerebellum—epilepsy syndrome	5.05e-05	0.00148	CbGeAlD
Procainamide—Asthenia—Zonisamide—epilepsy syndrome	5.02e-05	0.00063	CcSEcCtD
Procainamide—Agranulocytosis—Topiramate—epilepsy syndrome	5.01e-05	0.000629	CcSEcCtD
Procainamide—Angioedema—Pregabalin—epilepsy syndrome	4.97e-05	0.000624	CcSEcCtD
Procainamide—Hypersensitivity—Clonazepam—epilepsy syndrome	4.97e-05	0.000624	CcSEcCtD
Procainamide—Dizziness—Vigabatrin—epilepsy syndrome	4.96e-05	0.000623	CcSEcCtD
Procainamide—Confusional state—Valproic Acid—epilepsy syndrome	4.95e-05	0.000622	CcSEcCtD
Procainamide—Pruritus—Zonisamide—epilepsy syndrome	4.95e-05	0.000622	CcSEcCtD
Procainamide—Hypersensitivity—Phenytoin—epilepsy syndrome	4.94e-05	0.00062	CcSEcCtD
Procainamide—Urticaria—Lamotrigine—epilepsy syndrome	4.91e-05	0.000616	CcSEcCtD
Procainamide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	4.91e-05	0.000616	CcSEcCtD
Procainamide—Bradycardia—Topiramate—epilepsy syndrome	4.91e-05	0.000616	CcSEcCtD
Procainamide—Malaise—Pregabalin—epilepsy syndrome	4.91e-05	0.000616	CcSEcCtD
Procainamide—Nausea—Propofol—epilepsy syndrome	4.9e-05	0.000616	CcSEcCtD
Procainamide—Vomiting—Fosphenytoin—epilepsy syndrome	4.89e-05	0.000614	CcSEcCtD
Procainamide—Diarrhoea—Felbamate—epilepsy syndrome	4.89e-05	0.000614	CcSEcCtD
Procainamide—Body temperature increased—Lamotrigine—epilepsy syndrome	4.89e-05	0.000613	CcSEcCtD
Procainamide—Abdominal pain—Lamotrigine—epilepsy syndrome	4.89e-05	0.000613	CcSEcCtD
Procainamide—Dysgeusia—Gabapentin—epilepsy syndrome	4.89e-05	0.000613	CcSEcCtD
Procainamide—Dizziness—Diazepam—epilepsy syndrome	4.89e-05	0.000613	CcSEcCtD
Procainamide—Asthenia—Clonazepam—epilepsy syndrome	4.84e-05	0.000608	CcSEcCtD
Procainamide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.81e-05	0.000604	CcSEcCtD
Procainamide—Asthenia—Phenytoin—epilepsy syndrome	4.81e-05	0.000603	CcSEcCtD
Procainamide—Nausea—Midazolam—epilepsy syndrome	4.8e-05	0.000602	CcSEcCtD
Procainamide—Hallucination—Topiramate—epilepsy syndrome	4.8e-05	0.000602	CcSEcCtD
Procainamide—Diarrhoea—Zonisamide—epilepsy syndrome	4.79e-05	0.000601	CcSEcCtD
Procainamide—Asthenia—Oxcarbazepine—epilepsy syndrome	4.78e-05	0.0006	CcSEcCtD
Procainamide—Pruritus—Clonazepam—epilepsy syndrome	4.77e-05	0.000599	CcSEcCtD
Procainamide—Vomiting—Vigabatrin—epilepsy syndrome	4.77e-05	0.000599	CcSEcCtD
Procainamide—Pruritus—Phenytoin—epilepsy syndrome	4.74e-05	0.000595	CcSEcCtD
Procainamide—Nausea—Levetiracetam—epilepsy syndrome	4.74e-05	0.000595	CcSEcCtD
Procainamide—Metoclopramide—CHRM1—epilepsy syndrome	4.73e-05	0.0136	CrCbGaD
Procainamide—Dizziness—Felbamate—epilepsy syndrome	4.73e-05	0.000594	CcSEcCtD
Procainamide—Pruritus—Oxcarbazepine—epilepsy syndrome	4.72e-05	0.000592	CcSEcCtD
Procainamide—Convulsion—Pregabalin—epilepsy syndrome	4.71e-05	0.000592	CcSEcCtD
Procainamide—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.71e-05	0.000591	CcSEcCtD
Procainamide—Vomiting—Diazepam—epilepsy syndrome	4.7e-05	0.00059	CcSEcCtD
Procainamide—Anorexia—Valproic Acid—epilepsy syndrome	4.68e-05	0.000588	CcSEcCtD
Procainamide—Myalgia—Pregabalin—epilepsy syndrome	4.63e-05	0.000581	CcSEcCtD
Procainamide—Arthralgia—Pregabalin—epilepsy syndrome	4.63e-05	0.000581	CcSEcCtD
Procainamide—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.63e-05	0.000581	CcSEcCtD
Procainamide—Dizziness—Zonisamide—epilepsy syndrome	4.63e-05	0.000581	CcSEcCtD
Procainamide—Diarrhoea—Clonazepam—epilepsy syndrome	4.62e-05	0.000579	CcSEcCtD
Procainamide—Hypotension—Valproic Acid—epilepsy syndrome	4.59e-05	0.000576	CcSEcCtD
Procainamide—Asthenia—Carbamazepine—epilepsy syndrome	4.59e-05	0.000576	CcSEcCtD
Procainamide—Diarrhoea—Phenytoin—epilepsy syndrome	4.58e-05	0.000575	CcSEcCtD
Procainamide—Discomfort—Pregabalin—epilepsy syndrome	4.58e-05	0.000574	CcSEcCtD
Procainamide—Nausea—Fosphenytoin—epilepsy syndrome	4.57e-05	0.000574	CcSEcCtD
Procainamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.56e-05	0.000572	CcSEcCtD
Procainamide—Angioedema—Gabapentin—epilepsy syndrome	4.56e-05	0.000572	CcSEcCtD
Procainamide—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.55e-05	0.000572	CcSEcCtD
Procainamide—Vomiting—Felbamate—epilepsy syndrome	4.55e-05	0.000571	CcSEcCtD
Procainamide—Pruritus—Carbamazepine—epilepsy syndrome	4.52e-05	0.000568	CcSEcCtD
Procainamide—Malaise—Gabapentin—epilepsy syndrome	4.5e-05	0.000565	CcSEcCtD
Procainamide—Confusional state—Pregabalin—epilepsy syndrome	4.48e-05	0.000562	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.47e-05	0.000562	CcSEcCtD
Procainamide—Cardiac disorder—Topiramate—epilepsy syndrome	4.47e-05	0.000562	CcSEcCtD
Procainamide—Flushing—Topiramate—epilepsy syndrome	4.47e-05	0.000562	CcSEcCtD
Procainamide—Dizziness—Clonazepam—epilepsy syndrome	4.46e-05	0.00056	CcSEcCtD
Procainamide—Oxybuprocaine—BCHE—epilepsy syndrome	4.46e-05	0.0128	CrCbGaD
Procainamide—Nausea—Vigabatrin—epilepsy syndrome	4.46e-05	0.00056	CcSEcCtD
Procainamide—Vomiting—Zonisamide—epilepsy syndrome	4.45e-05	0.000559	CcSEcCtD
Procainamide—Asthenia—Lamotrigine—epilepsy syndrome	4.43e-05	0.000557	CcSEcCtD
Procainamide—Dizziness—Phenytoin—epilepsy syndrome	4.43e-05	0.000556	CcSEcCtD
Procainamide—Dizziness—Oxcarbazepine—epilepsy syndrome	4.41e-05	0.000553	CcSEcCtD
Procainamide—Nausea—Diazepam—epilepsy syndrome	4.39e-05	0.000551	CcSEcCtD
Procainamide—Diarrhoea—Carbamazepine—epilepsy syndrome	4.38e-05	0.000549	CcSEcCtD
Procainamide—Pruritus—Lamotrigine—epilepsy syndrome	4.37e-05	0.000549	CcSEcCtD
Procainamide—Shock—Pregabalin—epilepsy syndrome	4.37e-05	0.000548	CcSEcCtD
Procainamide—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.35e-05	0.000546	CcSEcCtD
Procainamide—Chills—Topiramate—epilepsy syndrome	4.33e-05	0.000543	CcSEcCtD
Procainamide—Convulsion—Gabapentin—epilepsy syndrome	4.32e-05	0.000543	CcSEcCtD
Procainamide—Vomiting—Clonazepam—epilepsy syndrome	4.29e-05	0.000538	CcSEcCtD
Procainamide—Decreased appetite—Valproic Acid—epilepsy syndrome	4.27e-05	0.000536	CcSEcCtD
Procainamide—Vomiting—Phenytoin—epilepsy syndrome	4.26e-05	0.000535	CcSEcCtD
Procainamide—Arthralgia—Gabapentin—epilepsy syndrome	4.25e-05	0.000533	CcSEcCtD
Procainamide—Myalgia—Gabapentin—epilepsy syndrome	4.25e-05	0.000533	CcSEcCtD
Procainamide—Nausea—Felbamate—epilepsy syndrome	4.25e-05	0.000533	CcSEcCtD
Procainamide—Vomiting—Oxcarbazepine—epilepsy syndrome	4.24e-05	0.000532	CcSEcCtD
Procainamide—Anorexia—Pregabalin—epilepsy syndrome	4.23e-05	0.000531	CcSEcCtD
Procainamide—Dizziness—Carbamazepine—epilepsy syndrome	4.23e-05	0.000531	CcSEcCtD
Procainamide—Diarrhoea—Lamotrigine—epilepsy syndrome	4.23e-05	0.000531	CcSEcCtD
Procainamide—Discomfort—Gabapentin—epilepsy syndrome	4.2e-05	0.000527	CcSEcCtD
Procainamide—Nausea—Zonisamide—epilepsy syndrome	4.16e-05	0.000522	CcSEcCtD
Procainamide—Hypotension—Pregabalin—epilepsy syndrome	4.15e-05	0.000521	CcSEcCtD
Procainamide—Chloroprocaine—BCHE—epilepsy syndrome	4.15e-05	0.0119	CrCbGaD
Procainamide—Dysgeusia—Topiramate—epilepsy syndrome	4.11e-05	0.000516	CcSEcCtD
Procainamide—Confusional state—Gabapentin—epilepsy syndrome	4.11e-05	0.000515	CcSEcCtD
Procainamide—CYP2D6—brain—epilepsy syndrome	4.1e-05	0.00121	CbGeAlD
Procainamide—Dizziness—Lamotrigine—epilepsy syndrome	4.09e-05	0.000513	CcSEcCtD
Procainamide—Vomiting—Carbamazepine—epilepsy syndrome	4.07e-05	0.00051	CcSEcCtD
Procainamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.05e-05	0.000508	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.05e-05	0.000508	CcSEcCtD
Procainamide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.02e-05	0.000504	CcSEcCtD
Procainamide—Nausea—Clonazepam—epilepsy syndrome	4.01e-05	0.000503	CcSEcCtD
Procainamide—Shock—Gabapentin—epilepsy syndrome	4.01e-05	0.000503	CcSEcCtD
Procainamide—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.99e-05	0.0005	CcSEcCtD
Procainamide—Nausea—Phenytoin—epilepsy syndrome	3.98e-05	0.0005	CcSEcCtD
Procainamide—Nausea—Oxcarbazepine—epilepsy syndrome	3.96e-05	0.000497	CcSEcCtD
Procainamide—Procaine—BCHE—epilepsy syndrome	3.95e-05	0.0114	CrCbGaD
Procainamide—Cinchocaine—BCHE—epilepsy syndrome	3.95e-05	0.0114	CrCbGaD
Procainamide—Vomiting—Lamotrigine—epilepsy syndrome	3.93e-05	0.000493	CcSEcCtD
Procainamide—Urticaria—Valproic Acid—epilepsy syndrome	3.9e-05	0.00049	CcSEcCtD
Procainamide—Ill-defined disorder—Topiramate—epilepsy syndrome	3.89e-05	0.000489	CcSEcCtD
Procainamide—Body temperature increased—Valproic Acid—epilepsy syndrome	3.88e-05	0.000487	CcSEcCtD
Procainamide—Abdominal pain—Valproic Acid—epilepsy syndrome	3.88e-05	0.000487	CcSEcCtD
Procainamide—Anorexia—Gabapentin—epilepsy syndrome	3.88e-05	0.000487	CcSEcCtD
Procainamide—Decreased appetite—Pregabalin—epilepsy syndrome	3.86e-05	0.000485	CcSEcCtD
Procainamide—Hypotension—Gabapentin—epilepsy syndrome	3.8e-05	0.000478	CcSEcCtD
Procainamide—Nausea—Carbamazepine—epilepsy syndrome	3.8e-05	0.000477	CcSEcCtD
Procainamide—Malaise—Topiramate—epilepsy syndrome	3.79e-05	0.000475	CcSEcCtD
Procainamide—Sunitinib—KDR—epilepsy syndrome	3.78e-05	0.0109	CrCbGaD
Procainamide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.71e-05	0.000466	CcSEcCtD
Procainamide—Moclobemide—CYP2C19—epilepsy syndrome	3.7e-05	0.0107	CrCbGaD
Procainamide—Nausea—Lamotrigine—epilepsy syndrome	3.67e-05	0.000461	CcSEcCtD
Procainamide—Feeling abnormal—Pregabalin—epilepsy syndrome	3.66e-05	0.000459	CcSEcCtD
Procainamide—Convulsion—Topiramate—epilepsy syndrome	3.64e-05	0.000457	CcSEcCtD
Procainamide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.63e-05	0.000456	CcSEcCtD
Procainamide—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.62e-05	0.000454	CcSEcCtD
Procainamide—Arthralgia—Topiramate—epilepsy syndrome	3.57e-05	0.000449	CcSEcCtD
Procainamide—Myalgia—Topiramate—epilepsy syndrome	3.57e-05	0.000449	CcSEcCtD
Procainamide—Decreased appetite—Gabapentin—epilepsy syndrome	3.54e-05	0.000444	CcSEcCtD
Procainamide—Discomfort—Topiramate—epilepsy syndrome	3.53e-05	0.000443	CcSEcCtD
Procainamide—Urticaria—Pregabalin—epilepsy syndrome	3.53e-05	0.000443	CcSEcCtD
Procainamide—Asthenia—Valproic Acid—epilepsy syndrome	3.52e-05	0.000442	CcSEcCtD
Procainamide—Abdominal pain—Pregabalin—epilepsy syndrome	3.51e-05	0.000441	CcSEcCtD
Procainamide—Body temperature increased—Pregabalin—epilepsy syndrome	3.51e-05	0.000441	CcSEcCtD
Procainamide—Pruritus—Valproic Acid—epilepsy syndrome	3.48e-05	0.000436	CcSEcCtD
Procainamide—Confusional state—Topiramate—epilepsy syndrome	3.45e-05	0.000434	CcSEcCtD
Procainamide—Shock—Topiramate—epilepsy syndrome	3.37e-05	0.000423	CcSEcCtD
Procainamide—Diarrhoea—Valproic Acid—epilepsy syndrome	3.36e-05	0.000422	CcSEcCtD
Procainamide—Feeling abnormal—Gabapentin—epilepsy syndrome	3.36e-05	0.000421	CcSEcCtD
Procainamide—Thrombocytopenia—Topiramate—epilepsy syndrome	3.35e-05	0.000421	CcSEcCtD
Procainamide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.33e-05	0.000418	CcSEcCtD
Procainamide—Hypersensitivity—Pregabalin—epilepsy syndrome	3.27e-05	0.000411	CcSEcCtD
Procainamide—Anorexia—Topiramate—epilepsy syndrome	3.27e-05	0.00041	CcSEcCtD
Procainamide—Dizziness—Valproic Acid—epilepsy syndrome	3.25e-05	0.000408	CcSEcCtD
Procainamide—Urticaria—Gabapentin—epilepsy syndrome	3.23e-05	0.000406	CcSEcCtD
Procainamide—Abdominal pain—Gabapentin—epilepsy syndrome	3.22e-05	0.000404	CcSEcCtD
Procainamide—Body temperature increased—Gabapentin—epilepsy syndrome	3.22e-05	0.000404	CcSEcCtD
Procainamide—Hypotension—Topiramate—epilepsy syndrome	3.2e-05	0.000402	CcSEcCtD
Procainamide—Asthenia—Pregabalin—epilepsy syndrome	3.19e-05	0.0004	CcSEcCtD
Procainamide—Pruritus—Pregabalin—epilepsy syndrome	3.14e-05	0.000394	CcSEcCtD
Procainamide—Vomiting—Valproic Acid—epilepsy syndrome	3.12e-05	0.000392	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.12e-05	0.000392	CcSEcCtD
Procainamide—Diarrhoea—Pregabalin—epilepsy syndrome	3.04e-05	0.000381	CcSEcCtD
Procainamide—Hypersensitivity—Gabapentin—epilepsy syndrome	3e-05	0.000377	CcSEcCtD
Procainamide—Decreased appetite—Topiramate—epilepsy syndrome	2.98e-05	0.000374	CcSEcCtD
Procainamide—Dizziness—Pregabalin—epilepsy syndrome	2.94e-05	0.000369	CcSEcCtD
Procainamide—Asthenia—Gabapentin—epilepsy syndrome	2.92e-05	0.000367	CcSEcCtD
Procainamide—Nausea—Valproic Acid—epilepsy syndrome	2.92e-05	0.000366	CcSEcCtD
Procainamide—Pruritus—Gabapentin—epilepsy syndrome	2.88e-05	0.000362	CcSEcCtD
Procainamide—Probenecid—ABCC2—epilepsy syndrome	2.84e-05	0.00816	CrCbGaD
Procainamide—Vomiting—Pregabalin—epilepsy syndrome	2.82e-05	0.000354	CcSEcCtD
Procainamide—Feeling abnormal—Topiramate—epilepsy syndrome	2.82e-05	0.000354	CcSEcCtD
Procainamide—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.8e-05	0.000352	CcSEcCtD
Procainamide—Aminohippurate—ABCC2—epilepsy syndrome	2.8e-05	0.00805	CrCbGaD
Procainamide—Diarrhoea—Gabapentin—epilepsy syndrome	2.79e-05	0.00035	CcSEcCtD
Procainamide—Moclobemide—CYP2D6—epilepsy syndrome	2.74e-05	0.0079	CrCbGaD
Procainamide—Urticaria—Topiramate—epilepsy syndrome	2.72e-05	0.000342	CcSEcCtD
Procainamide—Abdominal pain—Topiramate—epilepsy syndrome	2.71e-05	0.00034	CcSEcCtD
Procainamide—Body temperature increased—Topiramate—epilepsy syndrome	2.71e-05	0.00034	CcSEcCtD
Procainamide—Dizziness—Gabapentin—epilepsy syndrome	2.69e-05	0.000338	CcSEcCtD
Procainamide—Nausea—Pregabalin—epilepsy syndrome	2.64e-05	0.000331	CcSEcCtD
Procainamide—Vomiting—Gabapentin—epilepsy syndrome	2.59e-05	0.000325	CcSEcCtD
Procainamide—Hypersensitivity—Topiramate—epilepsy syndrome	2.52e-05	0.000317	CcSEcCtD
Procainamide—Asthenia—Topiramate—epilepsy syndrome	2.46e-05	0.000309	CcSEcCtD
Procainamide—Pruritus—Topiramate—epilepsy syndrome	2.42e-05	0.000304	CcSEcCtD
Procainamide—Nausea—Gabapentin—epilepsy syndrome	2.42e-05	0.000304	CcSEcCtD
Procainamide—Diarrhoea—Topiramate—epilepsy syndrome	2.34e-05	0.000294	CcSEcCtD
Procainamide—Dizziness—Topiramate—epilepsy syndrome	2.27e-05	0.000284	CcSEcCtD
Procainamide—Sunitinib—ABCC2—epilepsy syndrome	2.23e-05	0.00642	CrCbGaD
Procainamide—Vomiting—Topiramate—epilepsy syndrome	2.18e-05	0.000273	CcSEcCtD
Procainamide—Nausea—Topiramate—epilepsy syndrome	2.03e-05	0.000255	CcSEcCtD
Procainamide—Sunitinib—ABCG2—epilepsy syndrome	1.97e-05	0.00568	CrCbGaD
Procainamide—Probenecid—CYP2C19—epilepsy syndrome	1.97e-05	0.00567	CrCbGaD
Procainamide—Metoclopramide—CYP2D6—epilepsy syndrome	1.77e-05	0.00509	CrCbGaD
Procainamide—Lidocaine—CYP2D6—epilepsy syndrome	1.41e-05	0.00404	CrCbGaD
Procainamide—Benzocaine—ABCB1—epilepsy syndrome	1.23e-05	0.00354	CrCbGaD
Procainamide—Probenecid—ALB—epilepsy syndrome	1.09e-05	0.00315	CrCbGaD
Procainamide—Probenecid—ABCB1—epilepsy syndrome	1.04e-05	0.003	CrCbGaD
Procainamide—Aminohippurate—ABCB1—epilepsy syndrome	1.03e-05	0.00296	CrCbGaD
Procainamide—Lidocaine—ABCB1—epilepsy syndrome	1e-05	0.00289	CrCbGaD
Procainamide—Sunitinib—ABCB1—epilepsy syndrome	8.21e-06	0.00236	CrCbGaD
Procainamide—ACHE—Metabolism—CYP2D6—epilepsy syndrome	1.97e-06	2.47e-05	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—AKT1—epilepsy syndrome	1.97e-06	2.47e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP2C19—epilepsy syndrome	1.96e-06	2.46e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GRM4—epilepsy syndrome	1.95e-06	2.45e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GRM3—epilepsy syndrome	1.95e-06	2.45e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP11A1—epilepsy syndrome	1.95e-06	2.45e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.93e-06	2.43e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SSTR2—epilepsy syndrome	1.91e-06	2.4e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DUSP4—epilepsy syndrome	1.91e-06	2.4e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.91e-06	2.4e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.91e-06	2.4e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ATIC—epilepsy syndrome	1.89e-06	2.38e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—UPB1—epilepsy syndrome	1.89e-06	2.38e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NEU1—epilepsy syndrome	1.89e-06	2.38e-05	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—AKT1—epilepsy syndrome	1.89e-06	2.37e-05	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—AKT1—epilepsy syndrome	1.89e-06	2.37e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ADRA2A—epilepsy syndrome	1.88e-06	2.35e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CNR1—epilepsy syndrome	1.87e-06	2.35e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—POMC—epilepsy syndrome	1.87e-06	2.35e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—BCHE—epilepsy syndrome	1.87e-06	2.35e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.87e-06	2.34e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—HMOX1—epilepsy syndrome	1.86e-06	2.34e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GRM8—epilepsy syndrome	1.85e-06	2.32e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PGF—epilepsy syndrome	1.85e-06	2.32e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR2—epilepsy syndrome	1.84e-06	2.31e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—SST—epilepsy syndrome	1.84e-06	2.31e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CAT—epilepsy syndrome	1.84e-06	2.31e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CCL2—epilepsy syndrome	1.83e-06	2.3e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR7—epilepsy syndrome	1.83e-06	2.29e-05	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—AKT1—epilepsy syndrome	1.82e-06	2.29e-05	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—AKT1—epilepsy syndrome	1.82e-06	2.29e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	1.82e-06	2.29e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—POMC—epilepsy syndrome	1.81e-06	2.27e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.8e-06	2.26e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCG2—epilepsy syndrome	1.8e-06	2.25e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ABCB1—epilepsy syndrome	1.79e-06	2.24e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SLC2A1—epilepsy syndrome	1.78e-06	2.24e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCL2—epilepsy syndrome	1.77e-06	2.22e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.76e-06	2.21e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PLCB1—epilepsy syndrome	1.76e-06	2.21e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNAO1—epilepsy syndrome	1.76e-06	2.21e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OPRD1—epilepsy syndrome	1.76e-06	2.21e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.76e-06	2.21e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.76e-06	2.21e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP2D6—epilepsy syndrome	1.76e-06	2.21e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TH—epilepsy syndrome	1.76e-06	2.2e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP2C19—epilepsy syndrome	1.75e-06	2.2e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT3—epilepsy syndrome	1.74e-06	2.19e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP11A1—epilepsy syndrome	1.74e-06	2.18e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL12—epilepsy syndrome	1.73e-06	2.18e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.73e-06	2.18e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.73e-06	2.17e-05	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—epilepsy syndrome	1.72e-06	2.16e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CNR1—epilepsy syndrome	1.7e-06	2.14e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PLCB1—epilepsy syndrome	1.69e-06	2.13e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDYN—epilepsy syndrome	1.69e-06	2.12e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR7—epilepsy syndrome	1.69e-06	2.12e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GRM1—epilepsy syndrome	1.69e-06	2.12e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CHRM1—epilepsy syndrome	1.69e-06	2.12e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCG2—epilepsy syndrome	1.67e-06	2.1e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADRA2A—epilepsy syndrome	1.67e-06	2.1e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—POMC—epilepsy syndrome	1.67e-06	2.1e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GPX1—epilepsy syndrome	1.66e-06	2.09e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR7—epilepsy syndrome	1.66e-06	2.08e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.65e-06	2.08e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CCL2—epilepsy syndrome	1.63e-06	2.05e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP2C19—epilepsy syndrome	1.63e-06	2.05e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP11A1—epilepsy syndrome	1.62e-06	2.04e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HBEGF—epilepsy syndrome	1.61e-06	2.02e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.61e-06	2.02e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SLC2A1—epilepsy syndrome	1.59e-06	2e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CDC42—epilepsy syndrome	1.59e-06	1.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GFAP—epilepsy syndrome	1.59e-06	1.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GAL—epilepsy syndrome	1.59e-06	1.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT3—epilepsy syndrome	1.58e-06	1.99e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PLCB1—epilepsy syndrome	1.57e-06	1.97e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GRM5—epilepsy syndrome	1.57e-06	1.97e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CASP2—epilepsy syndrome	1.57e-06	1.97e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CHRM3—epilepsy syndrome	1.57e-06	1.97e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	1.57e-06	1.97e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.57e-06	1.97e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.57e-06	1.97e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TH—epilepsy syndrome	1.57e-06	1.97e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.54e-06	1.94e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	1.54e-06	1.93e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.51e-06	1.89e-05	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.5e-06	1.88e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.5e-06	1.88e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.5e-06	1.88e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	1.49e-06	1.88e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—BCHE—epilepsy syndrome	1.49e-06	1.87e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.48e-06	1.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.48e-06	1.85e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HMOX1—epilepsy syndrome	1.47e-06	1.84e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.46e-06	1.84e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP2D6—epilepsy syndrome	1.46e-06	1.84e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AGT—epilepsy syndrome	1.46e-06	1.83e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CAT—epilepsy syndrome	1.45e-06	1.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	1.44e-06	1.81e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	1.44e-06	1.8e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.43e-06	1.8e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—APOE—epilepsy syndrome	1.43e-06	1.79e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	1.42e-06	1.78e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.41e-06	1.77e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCB1—epilepsy syndrome	1.41e-06	1.77e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	1.4e-06	1.76e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TH—epilepsy syndrome	1.4e-06	1.76e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	1.4e-06	1.75e-05	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.39e-06	1.75e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADRA2A—epilepsy syndrome	1.39e-06	1.75e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—BCHE—epilepsy syndrome	1.39e-06	1.74e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.38e-06	1.73e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	1.38e-06	1.73e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	1.36e-06	1.7e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	1.32e-06	1.66e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	1.31e-06	1.64e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GPX1—epilepsy syndrome	1.31e-06	1.64e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.31e-06	1.64e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HMOX1—epilepsy syndrome	1.31e-06	1.64e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TH—epilepsy syndrome	1.3e-06	1.64e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.29e-06	1.62e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CAT—epilepsy syndrome	1.29e-06	1.62e-05	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—epilepsy syndrome	1.28e-06	1.61e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	1.28e-06	1.61e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.28e-06	1.61e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCB1—epilepsy syndrome	1.25e-06	1.58e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.25e-06	1.57e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.25e-06	1.57e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	1.25e-06	1.57e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POMC—epilepsy syndrome	1.23e-06	1.54e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	1.21e-06	1.52e-05	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—epilepsy syndrome	1.21e-06	1.52e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	1.2e-06	1.51e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	1.2e-06	1.51e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	1.2e-06	1.51e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	1.2e-06	1.51e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	1.2e-06	1.51e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	1.19e-06	1.49e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	1.17e-06	1.47e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GPX1—epilepsy syndrome	1.17e-06	1.46e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.16e-06	1.46e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CAT—epilepsy syndrome	1.15e-06	1.45e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AGT—epilepsy syndrome	1.15e-06	1.44e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.13e-06	1.42e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.13e-06	1.42e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOE—epilepsy syndrome	1.12e-06	1.41e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.12e-06	1.41e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	1.12e-06	1.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	1.12e-06	1.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	1.12e-06	1.41e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—epilepsy syndrome	1.12e-06	1.4e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	1.1e-06	1.38e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SST—epilepsy syndrome	1.09e-06	1.37e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	1.09e-06	1.37e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	1.09e-06	1.37e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	1.09e-06	1.37e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	1.08e-06	1.35e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CAT—epilepsy syndrome	1.07e-06	1.35e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.07e-06	1.34e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	1.06e-06	1.33e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	1.04e-06	1.31e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GPX1—epilepsy syndrome	1.04e-06	1.31e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	1.02e-06	1.29e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.02e-06	1.29e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AGT—epilepsy syndrome	1.02e-06	1.28e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	1.02e-06	1.28e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.02e-06	1.28e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.01e-06	1.27e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	1e-06	1.26e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	1e-06	1.26e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOE—epilepsy syndrome	1e-06	1.26e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	1e-06	1.26e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	9.8e-07	1.23e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—epilepsy syndrome	9.78e-07	1.23e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GPX1—epilepsy syndrome	9.71e-07	1.22e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—epilepsy syndrome	9.65e-07	1.21e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	9.51e-07	1.19e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	9.34e-07	1.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	9.28e-07	1.17e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	9.24e-07	1.16e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AGT—epilepsy syndrome	9.13e-07	1.15e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	9.12e-07	1.15e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	9.08e-07	1.14e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	9.01e-07	1.13e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	8.95e-07	1.12e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOE—epilepsy syndrome	8.95e-07	1.12e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—epilepsy syndrome	8.8e-07	1.1e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	8.63e-07	1.08e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—epilepsy syndrome	8.61e-07	1.08e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	8.54e-07	1.07e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	8.52e-07	1.07e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AGT—epilepsy syndrome	8.51e-07	1.07e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOE—epilepsy syndrome	8.34e-07	1.05e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	8.25e-07	1.04e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—epilepsy syndrome	7.85e-07	9.86e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	7.8e-07	9.8e-06	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—epilepsy syndrome	7.7e-07	9.67e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	7.69e-07	9.66e-06	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—epilepsy syndrome	7.69e-07	9.66e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	7.66e-07	9.62e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	7.59e-07	9.53e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	7.56e-07	9.49e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	7.54e-07	9.48e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	7.31e-07	9.18e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	7.29e-07	9.16e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	7.23e-07	9.08e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	7.21e-07	9.06e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TH—epilepsy syndrome	7.2e-07	9.04e-06	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—epilepsy syndrome	7.17e-07	9e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	7.01e-07	8.81e-06	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—epilepsy syndrome	7.01e-07	8.8e-06	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—epilepsy syndrome	6.87e-07	8.62e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	6.86e-07	8.62e-06	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—epilepsy syndrome	6.53e-07	8.21e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	6.52e-07	8.19e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	6.51e-07	8.18e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	6.38e-07	8.01e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	6.25e-07	7.85e-06	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	6.13e-07	7.7e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	6.02e-07	7.56e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	6.01e-07	7.55e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	5.99e-07	7.53e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CAT—epilepsy syndrome	5.93e-07	7.45e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	5.77e-07	7.24e-06	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	5.72e-07	7.18e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	5.48e-07	6.88e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	5.36e-07	6.74e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	5.36e-07	6.74e-06	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—epilepsy syndrome	4.91e-07	6.17e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	4.85e-07	6.09e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AGT—epilepsy syndrome	4.7e-07	5.91e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOE—epilepsy syndrome	4.61e-07	5.79e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	4.5e-07	5.65e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	4.41e-07	5.54e-06	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.1e-07	5.14e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	4.06e-07	5.1e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—epilepsy syndrome	3.96e-07	4.97e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	3.94e-07	4.95e-06	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—epilepsy syndrome	3.87e-07	4.86e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	3.84e-07	4.82e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	3.72e-07	4.67e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.61e-07	4.53e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	3.54e-07	4.44e-06	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—epilepsy syndrome	3.45e-07	4.33e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	3.44e-07	4.33e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.16e-07	3.97e-06	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—epilepsy syndrome	3.08e-07	3.87e-06	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—epilepsy syndrome	2.87e-07	3.61e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	2.2e-07	2.76e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.59e-07	1.99e-06	CbGpPWpGaD
